Key Indices


Top Stories
Small/Mid Cap Highlights | Medco Energi Internasional (MEDC IJ/NOT RATED/Rp1,495)
- MEDC's 1H26 production rose 19% yoy to 170 mboepd, in line with its 2026 guidance of 165-170 mboepd, driven by a 70% increase in Corridor working interest, first oil at Forel and first gas at Terubuk. Oil and gas contributed 92% of 1Q26 revenue, with 46% of volumes under fixed-price contracts. Net 2P reserves of 551 mmboe imply an 11.4-year RLI. Sambar, Rebonjaro, Sakakemang and Paus Biru underpin 2027 growth. Consensus expects AMMN earnings to reach US$953m, providing additional upside.
Technical Analysis
Chandra Daya Investasi | CDIA IJ
- Trading Buy Range: We have a technical Buy at Rp710, and take profit at Rp765.
Bank BTPN Syariah | BTPS IJ
- Trading Buy Range: We have a technical Buy at Rp1,010, and take profit at Rp1,060.
Top Stories
Small/Mid Cap Highlights | Medco Energi Internasional (MEDC IJ/NOT RATED/Rp1,495)
- MEDC's 1H26 production rose 19% yoy to 170 mboepd, in line with its 2026 guidance of 165-170 mboepd, driven by a 70% increase in Corridor working interest, first oil at Forel and first gas at Terubuk. Oil and gas contributed 92% of 1Q26 revenue, with 46% of volumes under fixed-price contracts. Net 2P reserves of 551 mmboe imply an 11.4-year RLI. Sambar, Rebonjaro, Sakakemang and Paus Biru underpin 2027 growth. Consensus expects AMMN earnings to reach US$953m, providing additional upside.
Technical Analysis
Chandra Daya Investasi | CDIA IJ
- Trading Buy Range: We have a technical Buy at Rp710, and take profit at Rp765.
Bank BTPN Syariah | BTPS IJ
- Trading Buy Range: We have a technical Buy at Rp1,010, and take profit at Rp1,060.
Key Indices


IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.



